Navigation Links
IOF Olof Johnell Science Award presented to Dr. Jonathan D. Adachi
Date:4/5/2014

Professor Jonathan D. Adachi M.D. has been named the winner of the International Osteoporosis Foundation's (IOF) 2014 Olof Johnell Science Award. Adachi is Professor and Alliance for Better Bone Health Chair in Rheumatology at the Department of Medicine of McMaster University.

The Olof Johnell Award is granted in recognition of extraordinary and internationally recognized contributions to the field of osteoporosis in a scientific or policy implementation area. The 2014 Award was presented at a ceremony held today at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in Seville, Spain.

IOF President John Kanis stated, "Jonathan (Rick) Adachi is a thought-leader in the bone field and highly deserving of this prestigious award. His epidemiological research and clinical studies have helped to advance our knowledge of risk factors and therapies for osteoporosis. He has also made notable contributions to the development of clinical guidelines and is an internationally recognized speaker and advocate on behalf of osteoporosis prevention."

Dr Adachi has conducted many clinical trials and has published extensively on a wide variety of therapies for the prevention and treatment of corticosteroid-induced and postmenopausal osteoporosis. As a result of his expertise he has participated in the development of clinical management guidelines in Canada. Dr Adachi is currently involved in the Canadian Multicentre Osteoporosis Study and is also focusing on the structural analysis of bone and cartilage as measured by pQCT and pMRI. He is the author of more than 400 scientific articles and book chapters. Dr. Adachi was awarded the First Annual Phillip Rosen Award in Rheumatology, the Lindy Fraser Award, and the Alliance for Better Bone Health Chair in Rheumatology at McMaster University. He received the North American Menopause Society award for Innovation in Osteoporosis Research. In 2012, he was awarded the Queen Elizabeth II Diamond Jubilee Medal for his work in osteoporosis.


'/>"/>

Contact: C. Jagait
cjagait@iofbonehealth.org
41-229-940-102
International Osteoporosis Foundation
Source:Eurekalert

Related biology news :

1. Inaugural IOF Olof Johnell Science Award presented to Professor Harry Genant
2. Academy of Natural Sciences receives major grant for program to protect drinking water
3. Research method integrates meditation, science
4. The science of champagne fizz: How many bubbles are in your bubbly?
5. Decline of natural history troubling for science, society
6. Elevating geosciences in the southeastern US: New ideas about old terranes
7. How the science of deer hunting can help patients with diabetes
8. Outstanding research on improving animal welfare in science
9. New bilateral pilot opportunity will fund collaborations between US and UK bioscience researchers
10. Three UTSA College of Sciences faculty honored at AAAS Annual Meeting
11. Elsevier announces the launch of OA journal: Colloid and Interface Science Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... 2017 Biopharm Reports has carried out ... of nuclear magnetic resonance spectroscopy (NMR). This involved ... current practices, developments, trends and end-user plans over ... and opportunities. These areas include growth in the ... and innovation requirements, hyphenated NMR techniques, main suppliers ...
(Date:1/19/2017)... and PUNE, India , January 19, 2017 ... Biometric Sensor Market, Opportunities and Forecast, 2014 - 2022," the global biometric ... CAGR of 9.6% from 2016 to 2022. In 2015, Asia-Pacific ... security for both public and private sectors. Continue ... ...
(Date:1/13/2017)... 2017 Sandata Technologies, LLC, a leading ... industry, including Electronic Visit Verification™ (EVV™), announced today ... as Senior Vice President of Product Management. ... homecare experience to Sandata, where he will be ... align Sandata,s suite of solutions with the needs ...
Breaking Biology News(10 mins):
(Date:2/17/2017)... , Feb. 17, 2017  Protagonist Therapeutics, ... data on its oral peptide drug candidates, PTG-100 ... of the European Crohn,s and Colitis Organization (ECCO).  ... Barcelona, Spain from February 15 ... detail preclinical data on Protagonist drug candidates PTG-100 ...
(Date:2/16/2017)... GREENWICH, Conn. , Feb. 16, ... focused on venture growth investments in biotechnology and ... Josh Richardson , M.D. to Managing Director. ... companies.  He is a board observer at InfaCare ... Longitude,s investments in Aimmune Therapeutics, Akebia Therapeutics, Cadence ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor Therapeutics, ... clinical-stage biotechnology company developing first-in-class biological therapies for ... it has elected to terminate its license agreement ... receptor agonists, including Cenderitide. "Our decision ... as we prioritize our efforts to advance our ...
(Date:2/16/2017)...  Dermata Therapeutics, LLC, a biotechnology company developing ... of dermatological diseases, today announced it has completed ... into a $5 million credit facility with Silicon ... capital for general corporate purposes to further Dermata,s ... of serious diseases treated by dermatologists.   ...
Breaking Biology Technology: